Duke researcher Louise Markert receives FDA approval for groundbreaking treatment of pediatric immune disorder
Duke alumna, scientist and pediatric immunologist Mary Louise Markert has dedicated her career to developing a cure for a fatal pediatric immune disorder. After 30 years of research, the Food and Drug Administration approved the immunotherapy she helped develop Oct. 8.